Induction of an immune response by a nonreplicating adenoviruses-based formulation versus a commercial pseudo-SARS-CoV-2 vaccine

• Autorzy: Baran J. , Kuryk L. , Garofalo M. , Pancer K. , Wieczorek M. , Kazek M. , Staniszewska M.
• Języki publikacji: EN
• Wydawca: -
• Czasopismo: BioTechnologia. Journal of Biotechnology Computational Biology and Bionanotechnology
• Rocznik: 2024
• Tom: 105
• Numer: 3
• Opis fizyczny: p.263-272,fig.,ref.

Twórcy

autor

Baran J.

• Centre for Advanced Materials and Technologies, Warsaw University of Technology, Warsaw, Poland

autor

Kuryk L.

• National Institute of Public Health National Institute of Hygiene (NIH) – National Institute of Research, Warsaw, Poland

autor

Garofalo M.

• Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy

autor

Pancer K.

• National Institute of Public Health National Institute of Hygiene (NIH) – National Institute of Research, Warsaw, Poland

autor

Wieczorek M.

• National Institute of Public Health National Institute of Hygiene (NIH) – National Institute of Research, Warsaw, Poland

autor

Kazek M.

• Centre for Advanced Materials and Technologies, Warsaw University of Technology, Warsaw, Poland

autor

Staniszewska M.

• Centre for Advanced Materials and Technologies, Warsaw University of Technology, Warsaw, Poland

Identyfikatory

DOI

10.5114/bta.2024.141805